In our study, we stained CD31 and CD105 as markers of MVD in breast cancer tissues, showing that MVD-CD105 level was associated with initial TNM stage, histological grade, and TDLNs metastasis in breast cancer, while MVD using CD31 was not associated with clinicopathological features (not shown). This evidence concerns the gene PECAM1 and breast carcinoma.